!!Ari Waisman - Curriculum Vitae
\\
__Qualifications and Career__
\\
* 1983 - 1986 Degree programme, Life Sciences, B.Sc., Tel Aviv University, Tel Aviv, IL\\
*1986 - 1988, Genetics, M.Sc., The Weizmann Institute of Science, Rehovot, IL\\
*Doctorate  1989 - 1994, Immunology, Ph.D, Mentor: Prof. E. Mozes, The Weizmann Institute of Science, Rehovot, IL\\
\\
__Stages of academic/professional career__
\\
*Since 2011, W3 Univ. Prof. and Director, Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University, Mainz\\
*2010 - 2011, Acting Director, Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University, Mainz\\
*2005 - 2010, W2 Univ. Prof. in the I. Medical Department, University Medical Centre of the Johannes Gutenberg University, Mainz\\
*2001 - 2005, Independent Group Leader, Laboratory for Molecular Immunology, Institute for Genetics, University of Cologne, Cologne, Germany\\
*2000 - 2001, Research Associate, Department of Immunology, Institute for Genetics, University of Cologne, Cologne, Germany\\
*1996 - 2000, Postdoctoral research with K. Rajewski, University of Cologne\\
*1994 - 1996, Postdoctoral research with L. Steinman, The Weizmann Institute of Science, Israel
\\
__Activities in the Research System__
\\
*Since 2023 Coordinator, TRR 355\\
*Since 2023 Member, Scientific Council of the Institute Pasteur, Paris\\
*Since 2022 Deputy Director, IMB International PhD Program \\
*Since 2022 Steering committee, SPP 2395 microglia\\
*Since 2019 Editorial Board, Neurology: Neuroimmunology and Neuroinflammation\\
*Since 2019 Director of the International Master of Biomedicine of the Universities of Mainz, Strasbourg and Luxembourg\\
*Since 2018 Steering Committee, SFB 1292\\
*Since 2018 Editor in Chief, Journal of Molecular Medicine\\
*Since 2018 Elected member of the board of German Society for Immunology (DGfI)\\
*2016 Sobek Forschungspreis - International multiple sclerosis research prize\\
*2015 - 2018 Coordinator, ERA-NET NEURON MELTRA-BBB\\
*Since 2015 Steering Committee, IMB International PhD Program\\
*2015 - 2022 Editorial Board, Cellular Immunology\\
*Since 2014 Editorial Board, Acta Neuropathologica\\
*2013 - 2016 Coordinator, EU ITN NeuroKine\\
*Since 2012 Advisory Board of Novartis on the role of IL-17A linking psoriasis with cardiovascular diseases\\
*Since 2012 Director, Master program in Biomedicine of the University of Mainz\\
*2012 - 2016 Elected member of the International Advisory Board of the International Society of Neuroimmunology (ISNI)\\
*Since 2012 Steering Committee, TRR 128\\
*Since 2010 Associate Editor BMC Immunology\\
*1998 - 2000 The European Community Long Term Fellowship\\
*1996 - 1998 The Human Frontier Science Program Fellowship (HFSPO)\\ \\[{ALLOW view All}][{ALLOW edit awaisman}][{ALLOW upload awaisman}][{ALLOW comment All}]